New blood markers could reveal hidden cancer after surgery
NCT ID NCT06929013
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at new blood tests that might help doctors know if any cancer is left after surgery for colorectal cancer that has spread to the lining of the abdomen. Researchers will track certain substances in the blood before and after surgery in 58 adults. The goal is to understand how these markers change over time and if they can give a more accurate picture than current methods.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PERITONEAL CARCINOMATOSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Hôpital Lyon Sud
RECRUITINGPierre-Bénite, 69310, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can Lab-Grown tumor models predict the best therapy for each patient?
- Triple chemo cocktail aims to clear deadly bowel blockages in advanced stomach cancer
- Chemotherapy sprayed directly into the abdomen: a new attack on stubborn cancers
- New drug combo aims to tackle Chemotherapy-Resistant colorectal cancer in the abdomen
- Light-Activated therapy shows promise for tumor control without surgery
- Cancer-Fighting virus shows promise in Hard-to-Treat ovarian cancer